 |
 |
IBD
- Page Path
-
- HOME
- TOPICS
- IBD
- IBD
- Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
- Fares Ayoub, Matthew Odenwald, Dejan Micic, Sushila R. Dalal, Joel Pekow, Russell D. Cohen, David T. Rubin, Atsushi Sakuraba
- Intest Res. 2022;20(2):240-250. Published online February 8, 2022
- Full text PubReader ePub PDF Supplementary Material
- Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
- Bhaskar Kante, Pabitra Sahu, Saurabh Kedia, Sudheer K. Vuyyuru, Kapil Soni, Maneesh Singhal, Raju Sharma, Govind Makharia, Vineet Ahuja
- Intest Res. 2022;20(2):231-239. Published online February 8, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
- Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei
- Intest Res. 2022;20(2):224-230. Published online February 8, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Drug therapy and monitoring for inflammatory bowel disease: a multinational questionnaire investigation in Asia
- Chenwen Cai, Juntao Lu, Lijie Lai, Dongjuan Song, Jun Shen, Jinlu Tong, Qing Zheng, Kaichun Wu, Jiaming Qian, Zhihua Ran
- Intest Res. 2022;20(2):213-223. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
- Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
- Intest Res. 2022;20(2):203-212. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Perspectives of East Asian patients and physicians on complementary and alternative medicine use for inflammatory bowel disease: results of a cross-sectional, multinational study
- Eun Soo Kim, Chung Hyun Tae, Sung-Ae Jung, Dong Il Park, Jong Pil Im, Chang Soo Eun, Hyuk Yoon, Byung Ik Jang, Haruhiko Ogata, Kayoko Fukuhara, Fumihito Hirai, Kazuo Ohtsuka, Jing Liu, Qian Cao, on behalf of the Clinical Research Committee of the Asian Organization for Crohn’s and Colitis
- Intest Res. 2022;20(2):192-202. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
- Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung, The Clinical Practice Guideline Committee of the Korean Association for the Study of the Intestinal Diseases (KASID)
- Intest Res. 2022;20(2):171-183. Published online January 5, 2022
- Full text PubReader ePub PDF
|
|
- Artificial intelligence for endoscopy in inflammatory bowel disease
- Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
- Intest Res. 2022;20(2):165-170. Published online January 7, 2022
- Full text PubReader ePub PDF
|
|
- Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?
- Sang Hyoung Park
- Intest Res. 2022;20(2):159-164. Published online April 29, 2022
- Full text PubReader ePub PDF
|
|
- Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
- Yong Eun Park
- Intest Res. 2022;20(2):157-158. Published online April 29, 2022
- Full text PubReader ePub PDF
|
|
- Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
- Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige
- Intest Res. 2022;20(1):150-155. Published online March 12, 2021
- Full text PubReader ePub PDF
|
|
- Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
- Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma
- Intest Res. 2022;20(1):134-143. Published online January 18, 2021
- Full text PubReader ePub PDF Supplementary Material
|
|
- Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
- Brigida Barberio, Edoardo Vincenzo Savarino, Timothy Card, Cristina Canova, Francesco Baldisser, Alessandro Gubbiotti, Davide Massimi, Matteo Ghisa, Fabiana Zingone
- Intest Res. 2022;20(1):114-123. Published online August 4, 2021
- Full text PubReader ePub PDF Supplementary Material
|
|
- Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy
- Danny Con, Bridgette Andrew, Steven Nicolaides, Daniel R van Langenberg, Abhinav Vasudevan
- Intest Res. 2022;20(1):101-113. Published online March 12, 2021
- Full text PubReader ePub PDF Supplementary Material
|
|
- Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity
- Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda
- Intest Res. 2022;20(1):90-100. Published online January 22, 2021
- Full text PubReader ePub PDF Supplementary Material
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.
